IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bios Capital Management, LP

Q4 2025 Holdings

Filed 2026-02-13 | 9 holdings | $82.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Actuate Therapeutics Inc(ACTU)COM005083100$61.5M10,049,99674.4%
Cognition Therapeutics Inc(CGTX)COM19243B102$8.1M6,000,0009.8%
Opus Genetics Inc(IRD)COM67577R102$7.4M3,683,4299.0%
Lantern Pharma Inc(LTRN)COM51654W101$3.1M1,009,5073.7%
Rein Therapeutics Inc(RNTX)COM NEW00887A204$2.0M1,690,7512.4%
In8bio Inc(INAB)COM NEW45674E208$593.0K253,4170.7%